| 000 | 01607 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514214744.0 | ||
| 264 | 0 | _c20050920 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.WNL.0000149516.30155.B8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHardmeier, M | |
| 245 | 0 | 0 |
_aRate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a. _h[electronic resource] |
| 260 |
_bNeurology _cJan 2005 |
||
| 300 |
_a236-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAtrophy |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWagenpfeil, S | |
| 700 | 1 | _aFreitag, P | |
| 700 | 1 | _aFisher, E | |
| 700 | 1 | _aRudick, R A | |
| 700 | 1 | _aKooijmans, M | |
| 700 | 1 | _aClanet, M | |
| 700 | 1 | _aRadue, E W | |
| 700 | 1 | _aKappos, L | |
| 773 | 0 |
_tNeurology _gvol. 64 _gno. 2 _gp. 236-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.WNL.0000149516.30155.B8 _zAvailable from publisher's website |
| 999 |
_c15346887 _d15346887 |
||